CAS: 1421372-66-8 - AZD9291DA HCl salt
- Sinónimos:
- Mutated EGFR-IN-1
- N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
![N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine](https://static.cymitquimica.com/products/AN/thumb/AG0039E9.jpg)
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
CAS:1421372-66-8
Fórmula:
C25H31N7O
Forma y color:
Solid
Peso molecular:
445.5599
Ref: AN-AG0039E9
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
Mutated EGFR-IN-1
CAS:1421372-66-8
Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, …
Fórmula:
C25H31N7O
Pureza:
99.73%
Forma y color:
Solid
Peso molecular:
445.56
Ref: TM-T16162
| 25mg | 57,00 € | |
| 50mg | 66,00 € | |
| 100mg | 88,00 € | |
| 200mg | 114,00 € | |
| 500mg | 183,00 € | |
| 1ml*10 (DMSO) | 49,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
Ref: 4Z-A-194031
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Mayo de 2024
N1-2-(Dimethylamino) ethyl) - 5- methoxy- N1- methyl- N4- (4- (1- methyl- 1H- indol- 3- yl) pyrimidin- 2- yl) benzene- 1, 2, 4- tria mine
CAS:1421372-66-8
Intermediate in the synthesis of osimertinib (AZD9291)
Fórmula:
C25H31N7O
Pureza:
Min. 95%
Peso molecular:
445.56 g/mol
Ref: 3D-FD162017
| 1mg | A consultar | |
| 2mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
